| Werner Arber |
Nobel Prize Laureate, Medicine 1978 |
|
|
|
|
| David Brown |
Chairman of the Board of Directors Babraham Bioscience Technologies |
|
|
|
|
| Hermann Bujard |
Executive Director, European Molecular Biology Organization (EMBO) |
|
| |
|
|
| Steven Burrill |
Chief Executive Officer, Burrill & Company |
|
|
|
|
| Alice Dautry |
Director General, Pasteur Institute |
|
|
|
|
| Jennie Hunter Cevera |
President, University of Maryland Biotechnology Institute (UMBI) |
|
|
|
|
| Emmanuel Chantelot |
Executive Director, European Biopharmaceutical Enterprises (EBE) |
|
|
|
|
| Brian Clark |
Chairman, Task Group on International Relations (TGIR), European Federation of Biotechnology |
|
|
|
|
| Rita Colwell |
Distinguished Professor, Centre for Bioinformatics and Computational Biology,
University of Maryland, Johns Hopkins Bloomberg School of Public Health, Chairman of Canon US Life Sciences, Former Director, National Science Foundation |
|
|
|
|
| Malcolm Elliott |
Executive Director, The Norman Borlaug Institute for Crop Improvement |
|
|
|
|
| Brent Erickson |
Executive Vice President, Industrial and Environmental Section, BIO |
|
|
|
|
| Carl Feldbaum |
President Emeritus, BIO, Board of Directors, BIO Ventures for Global Health |
|
|
|
|
| Frank Gannon |
Director General of Science Foundation Ireland, EMBO |
|
|
|
|
| Matthew M. Gardner |
President, BayBio |
|
|
|
|
| Jean-Pierre Garnier |
Chief Executive Officer, Glaxo Smith Kline (GSK) |
|
|
|
|
| Bernward Garthoff |
EuropaBio Vice President, Chairman Agrifood Council, Chairman of the Board German Association of Biotechnology Industries (DIB), Head European Policy, Bayer AG, Former Member of the Board of Management, Bayer Crop Science. |
|
|
|
|
| Clara Gaymard |
President, National Executive GE France |
|
|
|
|
| Roger Guillemin |
Nobel Prize Laureate, Medicine 1977, Distinguished Professor, The Salk Institute |
|
|
|
|
| Victoria Hale |
Founder, Chief Executive Officer & Chair of The Board of Directors, Institute for OneWorld Health |
|
|
|
|
| John Hodgson |
Editor-at-Large, Nature Biotechnology,
Director, Critical I |
|
|
|
|
| William B. Hurlbut |
Consulting Professor, The Neuroscience Institute at Stanford University Medical Center, Member of the President’s Council on Bioethics |
|
|
|
|
| Bruce W. Jenett |
Partner, Co-Chair, Global Life Sciences Sector, DLA Piper US LLP |
|
|
|
|
| Alastair Kent |
President of European Genetic Alliances’Network (EGAN), Director, Genetic Interest Group |
|
|
|
|
| Gerald T. Keusch |
Assistant Provost & Associate Dean for Global Health, Boston University, Former Director, The Fogarty International Centerat NIH |
|
|
|
|
| Jonathan K.C. Knowles |
President of Group Research, Member of the Executive Committee, Roche; Member of the Board of Genentech; Chair of EFPIA’s Research Director’s Group; Chairman of the Governing Board of the Innovative Medicines Initiative (IMI); |
|
|
|
|
| Carole A. Kovac |
Managing Director, Burrill & Company, Former General Manager, Life Science Solutions, IBM |
|
|
|
|
| Sir Peter Lachmann |
Past President, UK Academy of Medical Sciences |
|
|
|
|
| Federico Mayor |
Co-Chair of the UN High Level Group on the Alliance Civilizations, Former Director General, UNESCO |
|
|
|
|
| Eric M. Meslin |
Director, Indiana University, Center for Bioethics, Former Executive Director, National Bioethics Advisory Commission(NBAC) |
|
|
|
|
| Marc Van Montagu |
President, European Federation of Biotechnology, Chairman, Institute Plant Technology for Developing Countries, Ghent University |
|
|
|
|
| Osamu Nagayama |
Chairman of the Board of Directors, President & Chief Executive Officer, Chugai, Former President, Japan Pharmaceutical, Manufacturers Association (JPMA) |
|
| |
|
|
| Klaus Plate |
Chief Executive Officer, Heidelberg Technology Park; Former President International Association of Sciences Parks (IASP) |
|
|
|
|
| Bernard Poussot |
President & Chief Executive Officer, Wyeth |
|
|
|
|
| Ysbrand Poortman |
Secretary General, International Genetic Alliance, Former Chairman of the European Platform Patient Organisations, Science and Industry (EPPOSI) |
|
|
|
|
| Steen Riisgaard |
Chairman, EuropaBio, President & Chief Executive Officer, Novozymes |
|
|
|
|
| Diane Romza-Kutz |
Attorney-at-Law, Neal, Gerber & Eisenberg LLP |
|
|
|
|
| Theodore J. Roumel |
Vice President, Research, Innovation and Commercialisation, University of Maryland Biotechnology; Former Assistant Director, Technology Transfer, National Institutes of Health; Senior Advisor to the Pharmaceutical Research and Manufacturers of America (PhRMA) |
|
|
|
|
| Ellis Rubinstein |
President & Chief Executive Officer, The New York Academy of Sciences, Former Editor, Science |
|
|
|
|
| Albert Sasson |
Senior Visiting Professor, The United Nations University UNU-IAS, Former Assistant Director-General, UNESCO |
|
|
|
|
| Cynthia Schneider |
Executive Director, Perspectives in the Future of Science and Technology, Georgetown University, Former US Ambassador to The Netherlands |
|
| |
|
|
| Jeff Solomon |
Chef Executive Officer, ERBI Biotech Membership Association for Cambridge and the East of England |
|
|
|
|
| Donny Strosberg |
Professor Biomedical Research, Department of Infectology, Scripps Florida, Former Chairman and Chief Executive Officer Hybrigenics |
|
|
|
|
| Pierre Tambourin |
Chief Executive Officer of "Genopole Evry Ile de France"Biotech Science Park, Vice Chairman of Medicen Paris Region |
|
|
|
|
| Sandy Thomas |
Director of Foresight, Office of Science and Innovation, UK Government, Former Director, Nuffield Council on Bioethics |
|
|
|
|
| Johan Vanhemelrijck |
Secretary General, EuropaBio |
|
|
|
|
| Harriet Wallberg – Henriksson |
President, Karolinska Institutet, Member of Karolinska Institutet’s Nobel Assembly |
|
|
|
|
| Tony Weiss |
Director of the Molecular Biotechnology Program (MOBT), University of Sydney |
|
|
|
|
| Jean Weissenbach |
President, Genoscope National Sequencing Centre (CNS),
Member of the Pasteur Genopole Ile-de-France Steering Committee |
|
|
|
|
| Michael Zasloff |
Professor of Surgery and Paediatrics at Georgetown University, Senior Consultant, Life Sciences Investment Banking, Founder of Magainin Pharmaceuticals, Former Dean, Georgetown University School of Medicine |
|
